PFA-100 System
The PFA-100庐 System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.
The PFA-100 System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.
- Helps detect inherited, acquired and drug-induced platelet dysfunction
- Screening test for patients with impaired primary hemostasis, such as von Willebrand disease1
- Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients2
- Assesses the platelet dysfunction due to the effect of Aspirin
- Evaluates platelet dysfunction in children over 1 year of age3
- Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia
